|Last Price$89.59||Day Change (%)-3.20%|
|Open Price$92.47||Day Change ($)-2.96|
|Day Range89.56–92.47||52-Week Range82.05–110.01|
As of Thu 10/27/2016 1:53:00 PM | USD
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox® for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Mundipharma and Orexo Announce EU Regulatory Submission for Zubsolv®
Chugai's Alecensa® Receives Breakthrough Therapy Designation from FDA for First-Line Treatment of ALK Positive Non-Small Cell Lung Cancer
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...